erythromycin has been researched along with du-21220 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Theunissen, I; van Lierde, M | 1 |
| Gurbuz, A; Kabaca, C; Karateke, A | 1 |
| Arsenijević, S; Grujicić, D; Marinković, D; Milosević Djordjević, O | 1 |
1 trial(s) available for erythromycin and du-21220
| Article | Year |
|---|---|
Erythromycin treatment in idiopathic preterm labor.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant Mortality; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Prospective Studies; Ritodrine; Tocolysis; Tocolytic Agents; Treatment Outcome | 2004 |
5 other study(ies) available for erythromycin and du-21220
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Preterm premature rupture of the membranes: neonatal outcome in 215 cases of an active conservative management.
Topics: Ampicillin; Betamethasone; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Pregnancy; Pregnancy Outcome; Ritodrine | 1989 |
The effect of combined therapy with ritodrine, erythromycin and verapamil on the frequency of micronuclei in peripheral blood lymphocytes of pregnant women.
Topics: Adult; Cerclage, Cervical; Drug Therapy, Combination; Erythromycin; Female; Humans; Lymphocytes; Micronuclei, Chromosome-Defective; Micronucleus Tests; Pregnancy; Ritodrine; Tocolytic Agents; Uterine Cervical Incompetence; Verapamil | 2007 |